# clm_F12D855DD720

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: quarterly_research_and_development  
value: 947,300,000 United States dollar  
valid_from: 2009-03-31  
valid_to: 2009-06-30  
published: 2010-04-30  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_10AEF85D5BA1  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company quarterly research and development: 947,300,000 United States dollar", as of 2009-03-31 (until 2009-06-30). Claim clm_F12D855DD720, https://asof.is/claim/clm_F12D855DD720, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000095012310041274/0000950123-10-041274-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2010, filed 2010-04-30  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000095012310041274/0000950123-10-041274-index.htm (primary, SEC EDGAR 10-Q Q1 FY2010, published 2010-04-30)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | quarterly_research_and_development | 953,000,000 United States dollar | valid 2008-09-30 to 2009-03-31 | conf 0.95 | superseded | superseded_by [clm_F12D855DD720](/claim/clm_F12D855DD720.md) | [clm_5846C31AE43C](/claim/clm_5846C31AE43C.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.